The initiation of coverage by a reputable analyst firm like HC Wainwright & Co. with a Buy rating and a specific price target can significantly influence investor perception and confidence in Connect Biopharma Hldgs. This positive outlook is likely to attract attention to CNTB, potentially driving up its stock price in the short term as investors react to the analyst's recommendation.